The SPECTRA Study

NCT00537667 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

22

Enrollment

INDUSTRY

Sponsor class

Stopped The safety profile of combination therapy became unacceptable.

Conditions

Rheumatoid Arthritis

Interventions

DRUG: anakinra
DRUG: anakinra and PEG sTNF-R1

Sponsor

Amgen